Search

Find exactly what you’re looking for.

Showing 1-20 of 85 results

Over 8,000 stocks trade on American stock exchanges, [1] but billions of dollars in daily trades in these listed stocks and 12,000 more unlisted (non-exchange-traded) stocks occur outside of an exchange in Over-The-Counter ( “ OTC ” ) transactions. [2] A substantial portion of these trades involve...

Saul Ewing LLP, a full-service national law firm, is proud to announce that Intellectual Property Practice Co-Chair Bill Baton was selected by NJBIZ as a 2025 Leaders in Law honoree. The awards honor legal professionals whose dedication to their occupation and to their communities is outstanding...

Introduction In May 2022, a jury in the Circuit Court for Fairfax County, Virginia awarded Appian Corp. (Appian) in excess of $2 billion in damages from Pegasystems, Inc. (Pegasystems) for misappropriating Appian’s trade secrets in violation of the Virginia Uniform Trade Secrets Act (VUTSA). This...

Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the second quarter of 2024. If you would like to discuss...

Saul Ewing LLP is proud to announce that Charles M. Lizza, Vice Chair of the firm’s Litigation Department, was named to the NJBIZ 2024 Law Power 50 list. This is the sixth year in a row that Mr. Lizza has been included on this list of the state's top lawyers. Professionals are selected for the list...

NEW YORK, (JULY 15, 2024) – Saul Ewing LLP is expanding its Litigation Practice with two attorneys, Partners James Chou and Peter Zlotnick, who together bring more than 55 years of legal experience to their work representing clients in a variety of complex litigation. They are resident in the firm’s...

Introduction On June 18, 2024, the Federal Trade Commission (“FTC”) unanimously agreed to submit a comment supporting a recent proposed U.S. Patent and Trademark Office (“PTO”) rule that would mandate the disclosure of all settlement agreements made between parties appearing before the Patent Trial...

Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the first quarter of 2024. If you would like to discuss...

Please join Saul Ewing LLP and ARIAS U.S. for a half-day educational workshop and networking opportunity. For event inquiries, please contact info@arias-us.org. Panel Discussions Primer on Mass Tort Bankruptcies and Insolvencies The Current Lay of the Land, Including Scottish Re, Arrowood Crossroads...

This checklist highlights certain considerations for companies preparing to file annual reports on Form 10-K for the calendar year ended 2023 and is intended to serve as a focused resource highlighting changes in disclosure requirements and points of emphasis for the Securities and Exchange...

January 26, 2024 - With AI poised to reshape the practice of law and businesses in every industry, Saul Ewing is pleased to partner with the ABA’s Intellectual Property Litigation Committee in forming the AI Subcommittee. The AI Subcommittee will monitor legal and technological developments in this...

Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the fourth quarter of 2023. If you would like to discuss...

Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the third quarter of 2023. If you would like to discuss...

On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...

Minjae Kim maintains a broad civil litigation practice, assisting clients from pre-litigation investigation through appeal in complex commercial, intellectual property, and tax disputes. She has experience drafting dispositive motions, appellate briefs, and critical pleadings in state and federal...

Al Chakravarty helps to protect and defend organizations and individuals from issues that are enforced by federal and state agencies, including regulatory and compliance issues, whistleblower complaints, national security concerns, allegations of anti-competitive behavior, executive or employee...

Jason M. St. John is managing partner of Saul Ewing. As the chief executive officer, Jason oversees the firm's daily operations, client relations, strategic planning, business development and growth strategies. In leading Saul Ewing's national practice of 425 attorneys through its 18 offices located...

For More Information